HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Urinary markers of kidney injury and kidney function decline in HIV-infected women.

AbstractOBJECTIVE:
HIV-infected persons have substantially higher risk of kidney failure than persons without HIV, but serum creatinine levels are insensitive for detecting declining kidney function. We hypothesized that urine markers of kidney injury would be associated with declining kidney function among HIV-infected women.
METHODS:
In the Women's Interagency HIV Study, we measured concentrations of albumin-to-creatinine ratio, interleukin-18 (IL-18), kidney injury marker-1 (KIM-1), and neutrophil gelatinase-associated lipocalin from stored urine among 908 HIV-infected and 289 HIV-uninfected participants. Primary analyses used cystatin C-based estimated glomerular filtration rate (CKD-EPI eGFRcys) as the outcome, measured at baseline and 2 follow-up visits over 8 years; secondary analyses used creatinine (CKD-EPI eGFRcr). Each urine biomarker was categorized into tertiles, and kidney decline was modeled with both continuous and dichotomized outcomes.
RESULTS:
Compared with the lowest tertiles, the highest tertiles of albumin-to-creatinine ratio (-0.15 mL/min per 1.73 m, P < 0.0001), IL-18 (-0.09 mL/min per 1.73 m, P < 0.0001) and KIM-1 (-0.06 mL/min per 1.73 m, P < 0.001) were independently associated with faster eGFRcys decline after multivariate adjustment including all 3 biomarkers among HIV-infected women. Among these biomarkers, only IL-18 was associated with each dichotomized eGFRcys outcome: ≥3% (relative risk = 1.40; 95% confidence interval: 1.04 to 1.89); ≥5% (1.88; 1.30 to 2.71); and ≥10% (2.16; 1.20 to 3.88) for the highest versus lowest tertile. In alternative models using eGFRcr, the high tertile of KIM-1 had independent associations with 5% (1.71; 1.25 to 2.33) and 10% (1.78; 1.07 to 2.96) decline, and the high IL-18 tertile with 10% decline (1.97; 1.00 to 3.87).
CONCLUSIONS:
Among HIV-infected women in the Women's Interagency HIV Study cohort, novel urine markers of kidney injury detect risk for subsequent declines in kidney function.
AuthorsMichael G Shlipak, Rebecca Scherzer, Alison Abraham, Phyllis C Tien, Carl Grunfeld, Carmen A Peralta, Prasad Devarajan, Michael Bennett, Anthony W Butch, Kathryn Anastos, Mardge H Cohen, Marek Nowicki, Anjali Sharma, Mary A Young, Mark J Sarnak, Chirag R Parikh
JournalJournal of acquired immune deficiency syndromes (1999) (J Acquir Immune Defic Syndr) Vol. 61 Issue 5 Pg. 565-73 (Dec 15 2012) ISSN: 1944-7884 [Electronic] United States
PMID23023103 (Publication Type: Journal Article, Multicenter Study, Research Support, N.I.H., Extramural)
Chemical References
  • Acute-Phase Proteins
  • Biomarkers
  • HAVCR1 protein, human
  • Hepatitis A Virus Cellular Receptor 1
  • Interleukin-18
  • LCN2 protein, human
  • Lipocalin-2
  • Lipocalins
  • Membrane Glycoproteins
  • Proto-Oncogene Proteins
  • Receptors, Virus
  • Creatinine
Topics
  • AIDS-Associated Nephropathy (etiology, physiopathology, urine)
  • Acute-Phase Proteins (urine)
  • Adult
  • Albuminuria (urine)
  • Biomarkers (urine)
  • Case-Control Studies
  • Creatinine (urine)
  • Disease Progression
  • Female
  • Glomerular Filtration Rate
  • HIV Infections (physiopathology, urine)
  • Hepatitis A Virus Cellular Receptor 1
  • Humans
  • Interleukin-18 (urine)
  • Kidney (injuries, physiopathology)
  • Lipocalin-2
  • Lipocalins (urine)
  • Membrane Glycoproteins (urine)
  • Middle Aged
  • Proto-Oncogene Proteins (urine)
  • Receptors, Virus
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: